Work

EP13.07-10 A Study of Sintilimab Combined with Anlotinib and chemotherapy as Second-Line or Later Therapy in Extensive-Disease Small Cell Lung Cancer

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.1370

Authors: Z. Wang, X. Han, J. Guo, L. Li, Y. Huang, L. Ma, M. Zhao

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388077656

FWCI:

Cites:

Cited by:

Related to: 10